ROIVANT SCIENCES LTD. Income Taxes Paid
ROIVANT SCIENCES LTD. (ROIV) reported Income Taxes Paid of $48.37 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-05-20.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-05-20
- ROIVANT SCIENCES LTD. income taxes paid, net for fiscal 2026 was $48.37M, a 21.87% decline from fiscal 2025.
- ROIVANT SCIENCES LTD. income taxes paid, net for fiscal 2025 was $61.91M, a 401.13% increase from fiscal 2024.
- ROIVANT SCIENCES LTD. income taxes paid, net for fiscal 2024 was $12.35M, a 140.91% increase from fiscal 2023.
- ROIVANT SCIENCES LTD. income taxes paid, net for fiscal 2023 was $5.13M, a 459.83% increase from fiscal 2022.
| Period end | Income Taxes Paid, Net 12 month |
|---|---|
| 2026-03-31 | $48.37M 10-K · filed 2026-05-20 |
| 2025-03-31 | $61.91M 10-K · filed 2026-05-20 |
| 2024-03-31 | $12.35M 10-K · filed 2026-05-20 |
| 2023-03-31 | $5.13M 10-K · filed 2025-05-29 |
| 2022-03-31 | $916.00K 10-K · filed 2023-06-28 |
| 2021-03-31 | $4.08M 10-K · filed 2022-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |